Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience

The stagnation in drug development for schizophrenia highlights the need for better translation between basic and clinical research. Understanding the neurobiology of schizophrenia presents substantial challenges but a key feature continues to be the involvement of subcortical dopaminergic dysfuncti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kesby, JP, Eyles, DW, McGrath, JJ, Scott, JG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802623/
https://www.ncbi.nlm.nih.gov/pubmed/29382821
http://dx.doi.org/10.1038/s41398-017-0071-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802623/
https://www.ncbi.nlm.nih.gov/pubmed/29382821
http://dx.doi.org/10.1038/s41398-017-0071-9

Ejemplares similares